Myriad Genetics Inc (MYGN) is a diagnostics & research company listed on NASDAQ.
Latest reported MYGN revenue for 2025-12-31 was $824.5M. Net income was -$365.9M. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. MYGN currently screens at market cap $413.7M.
Use this MYGN page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the MYGN quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the MYGN SEC filings page. Lician reads the product cache first so this HTML stays unique to Myriad Genetics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full MYGN income, balance, and cash tables.